Amarin | AMRN - Market Capitalization

Stock Price
15.66
Daily Change
0.03 0.19%
Monthly
0.71%
Yearly
35.42%
Q1 Forecast
15.11

Amarin reported $323.7M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amarin USD 341M 4M Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
DBV Technologies USD 274M 17M Sep/2025
Esperion Therapeutics USD 340M 235M Dec/2023
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Halozyme Therapeutics USD 10.23B 2.31B Feb/2026
Heron Therapeutics USD 145M 6M Sep/2023
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Nektar Therapeutics USD 113M 4M Sep/2023
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025